Previous Article | Next Article 
Journal of Clinical Microbiology, November 1999, p. 3731-3732, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Importance of Selective Media for Recovery of
Yeasts from Clinical Specimens
Per
Sandven* and
Jørgen
Lassen
Department of Bacteriology, National
Institute of Public Health, 0462 Oslo, Norway
Received 3 May 1999/Returned for modification 25 June 1999/Accepted 22 July 1999
 |
ABSTRACT |
We compared the recovery of yeasts from clinical specimens cultured
on routine bacteriological media to the recovery of yeast from
specimens cultured on a selective fungal medium (Sabouraud agar). The
use of Sabouraud agar was especially important in cases of mixed
cultures, since in such cases yeast was recovered on bacteriological
media from only 50% of 44 yeast-positive pus specimens and from 22.5%
of 22 yeast-positive throat specimens. The use of a selective fungal
medium is therefore necessary to ensure the detection of yeast in
specimens containing a mixture of bacteria and yeasts. As a result,
clinicians must request yeast isolation when clinically indicated, and
the microbiological laboratory must add a selective fungal medium when
clinically significant yeasts are likely to be encountered. It is also
important that selective fungal media be used in clinical studies of
yeast infections.
 |
TEXT |
Yeasts are able to grow on routine
bacteriological media, such as blood agar and chocolate agar plates. If
yeasts are present together with a mixed bacterial population, it is,
however, possible that bacteria will suppress yeast growth. It is
therefore generally accepted that a selective medium such as Sabouraud
agar should be used for the cultivation of yeasts from clinical
specimens (6). Microbiological laboratories include such
media if a fungal or yeast culture has been requested by the clinician,
but if such a request has not been made, selective media are often omitted.
In order to assess the importance of including a selective fungal
medium, we compared the efficiency of yeast recovery from routine
bacteriological media and from Sabouraud agar. The design of the study
was quite simple, as we only wanted to investigate the impact of
selective fungal medium on the recovery of yeasts from clinical
specimens. No attempt was made to study the clinical importance of the
yeast isolates. In addition, we evaluated the methods used and the
ability of Norwegian microbiological laboratories to detect yeast in
mixed cultures by including specimens containing both bacteria and
yeasts in two recent distributions in the Norwegian external quality
assessment program for medical bacteriology, mycology, and parasitology
(10).
Comparative studies.
A total of 558 specimens, submitted as
pus specimens to the microbiological laboratory at the Norwegian Radium
Hospital, were included in the study. The origins of the specimens were
quite heterogeneous, including specimens from abdomens, abscesses,
wound and drain secretions, etc. The specimens were cultivated on
blood, chocolate, and lactose agar plates and on Sabouraud agar
(Acumedia Manufacturers, Inc., Baltimore, Md.). Streptomycin (40 µg/ml) and penicillin (13 µg/ml) were added to the Sabouraud agar
to inhibit bacterial growth. Anaerobic media were included if
appropriate. The bacteriological media were always inoculated before
the Sabouraud agar plate. All media were incubated at 37°C for
48 h, and the growth of yeasts was reported semiquantitatively as
light, moderate, or heavy.
Yeasts were detected in 50 of the 558 specimens (9%) (Table
1). Of these, six (12%) were pure
cultures, and the yeasts from these cultures were recovered on all
media. The remaining 44 yeast-positive specimens were mixed cultures,
and for half of these specimens, yeasts were recovered on Sabouraud
agar only. Sabouraud agar proved to be most useful when the specimens
in addition to the yeasts consisted of aerobic, gram-negative bacteria,
such as Escherichia coli, Klebsiella spp.,
Enterobacter spp., or Pseudomonas spp. (Table 1),
irrespective of the amount of yeast recovered. On rare occasions,
gram-negative rods grew on the Sabouraud agar, and it is, of course,
possible that yeasts were suppressed on some of these occasions.
Antibiotics other than streptomycin and penicillin could be added to
the Sabouraud agar if necessary.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Comparison of bacteriological media and Sabouraud agar
for the recovery of yeast from 50 yeast-positive pus specimens
|
|
A total of 41 throat samples were cultured on blood and chocolate agar
plates and on Sabouraud agar. All samples proved to be mixed cultures,
and yeasts were recovered from 22 (54%) of the specimens, of which 17 (77%) were detected on Sabouraud agar only (Table
2).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Comparison of bacteriological media and Sabouraud agar
for the recovery of yeast from 22 yeast-positive throat specimens
|
|
Of the 72 yeast strains recovered in this study, 42 strains were
identified to species level. The species were as follows: Candida
albicans (32 isolates), Candida glabrata (four
isolates), Candida parapsilosis (four isolates),
Candida krusei (one isolate), and Saccharomyces
cerevisiae (one isolate).
External quality assessment specimens.
Twenty-three
laboratories participate in the Norwegian external quality assessment
program. In 1998, a simulated abdominal pus specimen consisting of a
mixture of C. albicans, Proteus mirabilis, and
Bacteroides fragilis from a patient with peritonitis
following an intra-abdominal perforation was included in the program.
Fungal culture was not specifically requested, and in this case, only two laboratories included a selective fungal medium. These two laboratories detected C. albicans. Of the remaining 21 laboratories, which used no selective media, only eight (38%) detected
the yeast. In 1999, a similar specimen (C. albicans,
E. coli, and Enterococcus faecalis) was
distributed. Twelve laboratories used a selective fungal medium to
assess that sample. All of these, but only three (27%) of the 11 laboratories which did not use selective media, recovered C. albicans.
Discussion.
Yeasts in pure cultures are consistently isolated
on bacteriological media. However, yeasts are frequently present in
mixed cultures with different bacteria, and on such occasions, it is possible that bacteria will suppress yeast growth. Yeasts might, on the
other hand, suppress growth of slow-growing bacteria. In this study,
yeast was recovered on bacteriological media from only 50% of 44 yeast-positive pus specimens and from 22.5% of 22 yeast-positive
throat specimens consisting of mixed cultures. These results show that
yeasts in specimens submitted to the microbiological laboratory often
are suppressed by bacteria and are, therefore, not detected on the
routine bacteriological media used. The reason for this might be that
yeasts are overgrown by bacteria or are killed by bacterial toxins
(4, 5). It is therefore important that clinicians
specifically request yeast isolation when clinically indicated and that
microbiological laboratories employ a selective fungal medium when
clinically significant yeasts are likely to be encountered. In our
opinion, a selective fungal medium should, for instance, always be
included when processing abdominal pus specimens from patients with
intra-abdominal perforations. The results of several studies indicate
that yeasts are important pathogens in such situations (1, 7,
12).
Many studies on the significance of the recovery of yeasts from
clinical specimens unfortunately lack information on the media used for
the detection of yeasts (2, 3, 8, 9, 11). This omission of
information concerning methods makes the interpretation of such studies
difficult or impossible. The use of selective fungal media may have
important implications on the results and conclusions of a study.
The results of this study show the importance of using selective media
for the recovery of yeasts and the importance of specifying the methods
used for yeast recovery when reporting clinical studies of yeast infections.
 |
ACKNOWLEDGMENTS |
Excellent technical assistance was provided by Liv Bjelke.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Bacteriology, National Institute of Public Health, P.O. Box 4404 Torshov, N-0403 Oslo, Norway. Phone: 47 22 04 22 00. Fax: 47 22 04 25 18. E-mail: per.sandven{at}folkehelsa.no.
 |
REFERENCES |
| 1.
|
Calandra, T.,
J. Bille,
R. Schneider,
F. Mosimann, and P. Francioli.
1989.
Clinical significance of Candida isolated from peritoneum in surgical patients.
Lancet
2:1437-1440[Medline].
|
| 2.
|
Cornwell, E. E.,
H. Belzberg,
T. V. Berne,
W. R. Dougherty,
I. R. Morales,
J. Asensio, and D. Demetriades.
1995.
The pattern of fungal infections in critically ill surgical patients.
Am. Surg.
61:847-850[Medline].
|
| 3.
|
D'Amelio, L. F.,
B. Wagner,
S. Azimuddin,
J. P. Sutyak, and J. S. Hammond.
1995.
Antibiotic patterns associated with fungal colonization in critically ill surgical patients.
Am. Surg.
61:1049-1053[Medline].
|
| 4.
|
Hockey, L. J.,
N. K. Fujita,
T. R. Gibson,
D. Rotrosen,
J. Z. Montgomerie, and J. E. Edwards, Jr.
1982.
Detection of fungemia obscured by concomitant bacteremia: in vitro and in vivo studies.
J. Clin. Microbiol.
16:1080-1085[Abstract/Free Full Text].
|
| 5.
|
Kerr, J. R.
1994.
Suppression of fungal growth exhibited by Pseudomonas aeruginosa.
J. Clin. Microbiol.
32:525-527[Abstract/Free Full Text].
|
| 6.
|
Merz, W. G., and G. D. Roberts.
1995.
Detection and recovery of fungi from clinical specimens, p. 709-722.
In
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology. American Society for Microbiology, Washington, D.C
|
| 7.
|
Montravers, P.,
R. Gauzit,
C. Muller,
J. P. Marmuse,
A. Fichelle, and J. M. Desmonts.
1996.
Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy.
Clin. Infect. Dis.
23:486-494[Medline].
|
| 8.
|
Neumann, P. R., and S. R. Rakower.
1978.
The risk of positive cultures for Candida in the critically ill patient.
Crit. Care Med.
6:73-76[Medline].
|
| 9.
|
Pittet, D.,
M. Monod,
P. M. Suter,
E. Frenk, and R. Auckenthaler.
1994.
Candida colonization and subsequent infections in critically ill surgical patients.
Ann. Surg.
220:751-758[Medline].
|
| 10.
|
Sandven, P., and J. Lassen.
1994.
The Norwegian external quality assessment program for bacteriology, mycology and parasitology.
Med. Microbiol. Lett.
3:138-141.
|
| 11.
|
Slotman, G. J.,
E. Shapiro, and S. M. Moffa.
1994.
Fungal sepsis: multisite colonization versus fungemia.
Am. Surg.
60:107-113[Medline].
|
| 12.
|
Solomkin, J. S.,
A. B. Flohr,
P. G. Quie, and R. L. Simmons.
1980.
The role of Candida in intraperitoneal infections.
Surgery
88:524-530[Medline].
|
Journal of Clinical Microbiology, November 1999, p. 3731-3732, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Meyer, M.-H., Letscher-Bru, V., Jaulhac, B., Waller, J., Candolfi, E.
(2004). Comparison of Mycosis IC/F and Plus Aerobic/F Media for Diagnosis of Fungemia by the Bactec 9240 System. J. Clin. Microbiol.
42: 773-777
[Abstract]
[Full Text]